Skip Navigation

European Heart Journal 1999 20(12):867-871; doi:10.1053/euhj.1998.1393
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rydén, L.
Right arrow Articles by Remme, W.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rydén, L.
Right arrow Articles by Remme, W.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Treatment of congestive heart failure. Has the time come for decreased complexity?

L. Rydéna,f1 and W.J. Remmeb

a Department of Cardiology, Karolinska Hospital, Stockholm, Sweden
b Sticares, Cardiovascular Research Foundation, Rotterdam, The Netherlands

Received October 13, 1998; accepted October 21, 1998

Key Words: Congestive heart failure, pharmacological therapy, beta-blockers, ACE inhibitors, mortality, morbidity

f1 Correspondence: L. Rydén MD FESC, Department of Cardiology, Karolinska Hospital, S-171 46 Stockholm, Sweden.

References

  1. The Task Force of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J. 1995;16:741–751[Free Full Text]
  2. The Task Force of the European Society of Cardiology. Guidelines for the treatment of heart failure. Eur Heart J. 1997;18:736–753[Free Full Text]
  3. N Engl J Med. 1987;316:1429–1435[Abstract]
  4. The SOLVD Investigators. Effects on enalapril on mortality and the development of heart failure in asymtomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–691[Abstract]
  5. Cohn JN, Johnson G, Ziesche S. A comparison of enalapril with hydralazine-isosorbiede dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303–310[Abstract]
  6. N Engl J Med. 1991;325:293–302[Abstract]
  7. Packer M, Carver JR, Rodeheffer RJ. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325:1468–1475[Abstract]
  8. Feldman A, Young J, Bourge R. Mechanism of increased mortality from vesnarinone in the severe heart failure trial (VEST). J Am Coll Card. 1997;29(2 Suppl A):64A
  9. Waagstein F, Bristow MR, Swedberg K. Beneficial effects of metoprolol in idopathic dilated cardiomyopathy. Lancet. 1993;342:1441–1446[CrossRef][Web of Science][Medline]
  10. CIBIS Investigators and Committees. A randomised trial of beta-blockade in heart failure: the Cardiac Insufficiency Bisoprolol study (CIBIS). Circulation. 1994;90:1765–1773[Medline]
  11. Feurstein GZ, Schusterman NH, Ruffalo RR. Carvedilol update IV: prevention of oxidative stress, cardiac remodelling and progression of congestive heart failure. Drugs Today. 1997;33:453–457
  12. Packer M, Bristow MR, Cohn J. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355[Abstract/Free Full Text]
  13. Australia/New Zealand Heart Failure Collaborative Group. Randomised placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet. 1996;349:375–380
  14. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J. 1994;71:584–587[Abstract/Free Full Text]
  15. Packer M, Poole-Wilson P, Armstrong P. Comparative effects of low-dose versus high-dose lisinopril on survival and major events in chronic congestive heart failure: the assessment of treatment with lisinopril and survival study (ATLAS). Eur Heart J. 1998;19:905
  16. Bristow MR, Gilbert EM, Abraham WT. Carvedilol produces dose-related improvements in left ventricular failure. MOCHA Investigators. Circulation. 1996;94:2807–2816[Abstract/Free Full Text]
  17. Sabbah HN, Shimoyama H, Kono T. Effects of long term monotherapy with enalapril, metoprolol and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation. 1994;89:2852–2859[Abstract/Free Full Text]
  18. Doughty RN, Whally GA, Gamble G. Left ventricular remodelling in patients with congestive heart failure due to ischemic heart disease. J am Coll Card. 1997;29:1060–1066[Abstract]
  19. Lowes D, Gill EA, Rodriguez-Larrain J. Carvedilol is associated with a reversal of remodelling in chronic heart failure. Circulation. 1996;94(8 Suppl 1):I-407–A 2371
  20. Senior R, Basu S, Lahiri A. Carvedilol prevents remodelling and improves prognosis in patients with left ventricular dysfunction following acute myocardial infarction. J Am Coll Card. 1997;27:319A
  21. Gilbert EM, Colucci WS, Fowler WS. Carvedilol without ACE-inhibition in the treatment of patients with moderate to severe chronic heart failure. Circulation. 1996;94 (Suppl):I-663–A 3875
  22. Janson K, Karlberg KE, Nylander E. More favourable haemodynamic effects from metoprolol than from captopril in patients with dilated cardiomyopathy. Eur Heart J. 1997;18:1115–1121[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur J Heart FailHome page
J. Korewicki, S. Rywik, and T. Rywik
Management of heart failure patients in Poland
Eur J Heart Fail, March 1, 2002; 4(2): 215 - 219.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rydén, L.
Right arrow Articles by Remme, W.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rydén, L.
Right arrow Articles by Remme, W.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?